Older patients comprise a growing subset of medical cannabis patients, according to a new study. Titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada, the new scientific publication presented the consumption trends observed in patients and the self-reported impacts of medical cannabis in alleviating the patients' primary symptoms. Tilray Medical, a division of Tilray Brands, Inc. is behind the study which is derived from the Canadian Cannabis Patient Survey (CCPS) 2021, which included 2,697 patients. The researchers focused primarily on older patients with a mean age of 54.3. Patients with chronic pain (27.8%), arthritis (14.9%) and anxiety (9%) were the most numerous among those seeking cannabis to treat their primary illnesses. Pain was the most common primary symptom for which patients use medical cannabis, followed by anxiety and insomnia/sleep disorder.
Bank of America's Michael Hartnett's insights reveal common catalysts for market bubbles, including tech innovation and central bank easing. Historic parallels to current Magnificent Seven stocks show potential for future burst, with rising Treasury yields as a harbinger.
Buffett's portfolio moves closely influence markets. Late Wednesday, his holding company, Berkshire Hathaway, filed its quarterly 13F report with the SEC.
Google has committed to investing 25 million euros ($26.98 million) in Europe to foster AI skills. The company will be working with social enterprises and non-profits to ensure that the training reaches those who stand to benefit the most.
A 2018 compensation plan for Elon Musk from Tesla's Board of Directors was voided by a judge. A look at how much Tesla stock is up since the plan was announced.